Moderna announces phase 1/2 data on mrna-3927, an investigational mrna therapy for propionic acidemia (pa) to be presented at the 2023 asgct annual meeting
After completing enrollment in 5 dose cohorts, and with no dose-limiting safety signals observed to date by the independent dsmb, the phase 1/2 trial of mrna-3927 advances to the dose-expansion phase to determine a recommended dose cambridge, ma / accesswire / may 3, 2023 / moderna,inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that an abstract reporting on interim data from the phase 1/2 trial of mrna-3927, an investigational mrna therapy for propionic acidemia (pa) has been accepted for presentation at the 2023 american society of gene + cell therapy (asgct) annual meeting being held may 16-20, 2023 in los angeles, ca. the presentation details are as follows: title: mrna-3927 therapy for propionic acidemia: interim data from a phase 1/2 studysession: metabolic, storage, endocrine, liver, and gastrointestinal diseases ii date/time: thursday, may 18, 2023, 04:45 pm - 05:00 pm ptpresenter: gerald s.
MRNA Ratings Summary
MRNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission